Liming Chen
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Biological Activity of Diterpenoids and Biflavonoids 2
- S100 Proteins and Annexins 2
-
- Atrial Fibrillation Management and Outcomes 2
- Co-authors
- Weimin Wang (1 shared paper)Liangliang Dong (1 shared paper)Songming Ding (1 shared paper)Shusen Zheng (1 shared paper)Fei Chen (1 shared paper)Xiaobo Yu (1 shared paper)Jun Cheng (1 shared paper)Wu Zhang (1 shared paper)
- Journals
- Swarm and Evolutionary Computation (2 papers)Coronary Artery Disease (2 papers)Diagnostic Pathology (1 paper)Medicine (1 paper)International Journal of Cardiology (1 paper)
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Liming Chen
42 papers receiving 326 citations
Peers
Comparison fields: 5 of 62
- Hepatology 59
- Cancer Research 106
- Endocrinology 14
- Molecular Biology 111
- Oncology 27
Countries citing papers authored by Liming Chen
This map shows the geographic impact of Liming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Chen more than expected).
Fields of papers citing papers by Liming Chen
This network shows the impact of papers produced by Liming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Chen. The network helps show where Liming Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Liming Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 72 | |
| 2 | 2018 | 48 | |
| 3 | 2015 | 37 | |
| 4 | 2009 | 20 | |
| 5 | Identification of Escherichia coli O157:H7 by multiplex PCR with primers specific to the hlyA, eaeA, stx1, stx2, fliC and rfb genes. | 2002 | 16 |
| 6 | 2011 | 12 | |
| 7 | 2021 | 11 | |
| 8 | 2015 | 11 | |
| 9 | 2017 | 11 | |
| 10 | Influence of chronic kidney disease on the outcome of patients with chronic total occlusion. | 2016 | 9 |
| 11 | 2018 | 8 | |
| 12 | 2021 | 6 | |
| 13 | 2020 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2019 | 5 | |
| 16 | Cytological and molecular identification of cytoplasm in two male sterile lines in radish. | 2009 | 4 |
| 17 | 2017 | 4 | |
| 18 | 2019 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2022 | 3 |
About Liming Chen
Liming Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Surgery and Oncology, having authored 45 papers that have together received 327 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Hepatitis B Virus Studies (2 papers), Biological Activity of Diterpenoids and Biflavonoids (2 papers), Medicinal Plant Pharmacodynamics Research (2 papers), Traditional Chinese Medicine Studies (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), S100 Proteins and Annexins (2 papers) and Coronary Interventions and Diagnostics (2 papers). The work is most often cited by research in Hepatology (59 citations), Cancer Research (106 citations), Endocrinology (14 citations), Molecular Biology (111 citations) and Oncology (27 citations). Liming Chen has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Weimin Wang, Liangliang Dong, Songming Ding, Shusen Zheng, Fei Chen, Xiaobo Yu, Jun Cheng, Wu Zhang, Haijun Guo and Chunyang Xing. Their work appears in journals such as Swarm and Evolutionary Computation, Coronary Artery Disease, Diagnostic Pathology, Medicine and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.